FindTrial
Sign In

Can the safety of minimally invasive distal pancreatectomy be advanced one step further identifying patients at high risk of massive perioperative blood loss by a novel nomogram

Can the safety of minimally invasive distal pancreatectomy be advanced one step further identifying patients at high risk of 3 massive perioperative blood loss by a novel nomogram

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072146
Enrollment
Unknown
Registered
2023-06-05
Start date
2023-06-05
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic tumors

Interventions

Trail group:NA

Sponsors

Fujian Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 81 Years

Inclusion criteria

Inclusion criteria: Patients who were scheduled to undergo MIDP by the same surgery team at Fujian Medical University Union Hospital between January 2016 and August 2022.

Exclusion criteria

Exclusion criteria: 1. They underwent conversion to open surgery; 2. Laparoscopic or robot-assisted surgery; 3. Data on operative time, hemoglobin and waist circumference were missing.

Design outcomes

Primary

MeasureTime frame
Blood routine;Surgical time;Operation;Pathology of neoplasia;—

Secondary

MeasureTime frame
Blood lipid test;Albumin;Age;Sex;Height;Weight;Waist circumference;Tumor size;Hypertension;Diabetes mellitus;Abdominal surgery history;Coagulation function test;—

Countries

China

Contacts

Public ContactFengchun Lu

Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian

fengchun160lu@fjmu.edu.cn+86 199 0500 5634

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026